Finally, among the top KEGG pathways identified were the p53 signaling pathway, renal cell carcinoma, miRNAs in cancer, chronic myeloid leukemia, platinum drug resistance, and cell cycle (Figure 2b). This evidence concerns the gene TP53 and renal cell carcinoma.